Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Richard Scheller
Age : 66
Public asset : 5,881,797 USD
Country of residence : Unknown
Linked companies : BridgeBio Pharma, Inc. - 23andMe Holding Co. - DICE Therapeutics, Inc. - Alector, Inc. - ORIC Pharmaceuticals, Inc.

Biography of Richard Scheller 
Dr. Richard H. Scheller is an Independent Director at Alector, Inc., a Director, Chairman-Research & Development at BridgeBio Pharma LLC, an Independent Director at Oric Pharmaceuticals, Inc., a Chairman at DICE Molecules SV LLC, a Director, Chairman-Research & Development at BridgeBio Pharma, Inc., a Member at American Academy of Arts & Sciences, a Member at National Academy of Medicine of United States and a Member at National Academy of Sciences. He is on the Board of Directors at Maze Therapeutics, Inc., Alector, Inc., BridgeBio Pharma LLC, DiCE Molecules, Inc., 23andMe, Inc., Oric Pharmaceuticals, Inc., Dice Molecules Holdings LLC, Rafael Pharmaceuticals, Inc., BridgeBio Pharma, Inc. and Fine Arts Museums of San Francisco. Dr. Scheller was previously employed as an Independent Director by Xenon Pharmaceuticals, Inc., a Director & Chief Scientific Officer by Medrio, Inc., a Head-Genentech Research & Early Development by Roche Holding AG, an Executive VP-Research & Early Development by Genentech, Inc., and an Associate Professor by Stanford University. He also served on the board at Affinita Biotech, Inc. He received his undergraduate degree from the University of Wisconsin, a doctorate degree from The Trustees of Columbia University in The City of New York and a doctorate degree from California Institute of Technology.


Current positions of Richard Scheller 
Holdings of Richard Scheller 
Richard Scheller : Personal Network 
Most Read News 
09/22WILLIAM ACKMAN : Ackman's Pershing Square fund surges as Universal soars in stock debut
RE
09/24CATHIE WOOD : Chinese crackdown on bitcoin another blow to Cathie Wood's ARK ETF
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/22CATHIE WOOD : ARK's Cathie Wood says Wall Street not in a bubble
RE
09/24ELON MUSK : New semiconductor plants will end global auto chip shortage next year -Tesla's Musk
RE
09/21JEFF BEZOS : UK's Johnson discussed taxation with Amazon's Bezos
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
09/24BARRY DILLER : Stock Futures Weaken After Evergrande Payment Deadline Passes
DJ
More news


© 2021 People and Ownership :   
Richard Scheller : Connections 


Latest news about Richard Scheller 
06/1623andMe, Inc. completed the acquisition of VG Acquisition Corp. from VG Acquisition Sponsor LLC and others in a reverse merger transaction.
CI
02/0423andMe, Inc. entered into a definitive merger agreement to acquire VG Acquisition Corp. from VG Acquisition Sponsor LLC and others in a reverse merger transaction for $5.8 billion.
CI
2020Xenon Pharmaceuticals Inc. Announces Management Changes
CI
2019BridgeBio Pharma, Inc. Announces Appointment of Jennifer Cook as Board Member
CI
2019Alector, Inc. Appoints Richard Scheller and Thomas Südhof as Co-Chairs of the Company’S Strategic Portfolio Advice and Review Committee
CI
2018Alector Announces Board Appointments
CI
2018GSK bets $300 million on genetics as CEO plays down break-up talk
RE
More news